XKRX
353810
Market cap132mUSD
Jul 10, Last price
6,230.00KRW
1D
3.49%
1Q
-14.77%
IPO
371.61%
Name
Easy Bio Inc
Chart & Performance
P/E
7.42
P/S
0.43
EPS
839.66
Div Yield, %
—
Shrs. gr., 5y
9.46%
Rev. gr., 5y
40.18%
Revenues
476.94b
+24.10%
Net income
27.78b
+41.69%
CFO
34.65b
+34.55%
Dividend
Dec 27, 2023100 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 2020 and headquartered in Seoul, South Korea, EASY BIO, Inc. offers expert solutions, including specialized feed and dietary supplements, for piglets to customers throughout South Korea and on a global scale.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||